These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28646023)

  • 1. Amlexanox Downregulates S100A6 to Sensitize
    Tamai H; Yamaguchi H; Miyake K; Takatori M; Kitano T; Yamanaka S; Yui S; Fukunaga K; Nakayama K; Inokuchi K
    Cancer Res; 2017 Aug; 77(16):4426-4433. PubMed ID: 28646023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of S100A6 induces GVL effects in MLL/AF4-positive ALL in human PBMC-SCID mice.
    Tamai H; Miyake K; Yamaguchi H; Shimada T; Dan K; Inokuchi K
    Bone Marrow Transplant; 2014 May; 49(5):699-703. PubMed ID: 24583627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of MLL-AFF1-positive acute lymphoblastic leukemia to tumor necrosis factor-alpha is mediated by S100A6 upregulation.
    Tamai H; Miyake K; Yamaguchi H; Takatori M; Dan K; Inokuchi K; Shimada T
    Blood Cancer J; 2011 Nov; 1(11):e38. PubMed ID: 22829076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia.
    Wu Z; Eguchi-Ishimae M; Yagi C; Iwabuki H; Gao W; Tauchi H; Inukai T; Sugita K; Ishii E; Eguchi M
    Br J Haematol; 2015 Dec; 171(5):818-29. PubMed ID: 26403224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion.
    Tretti Parenzan C; Molin AD; Longo G; Gaffo E; Buratin A; Cani A; Boldrin E; Serafin V; Guglielmelli P; Vannucchi AM; Cazzaniga G; Biondi A; Locatelli F; Meyer LH; Buldini B; Te Kronnie G; Bresolin S; Bortoluzzi S
    Blood Adv; 2024 Mar; 8(5):1305-1319. PubMed ID: 38029383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV8 vector expressing IL24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4-positive ALL model mice.
    Tamai H; Miyake K; Yamaguchi H; Takatori M; Dan K; Inokuchi K; Shimada T
    Blood; 2012 Jan; 119(1):64-71. PubMed ID: 22025528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1".
    da Fonseca Bastos ACS; da Silva Rezende AC; Ferreira LB; Blunck CB; Pombo-de-Oliveira MS; Emerenciano M; Gimba ERP
    Leuk Res; 2020 Apr; 91():106316. PubMed ID: 32114371
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic and Epigenetic Characterization of a Discordant
    Russo A; Viberti C; Mareschi K; Casalone E; Guarrera S; Birolo G; Cazzaniga G; Corral L; Trentin L; Basso G; Fagioli F; Matullo G
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a human induced pluripotent stem cell line harboring the infant leukemia-associated fusion gene, KMT2A-AFF1 (IMSUTi002-A-2).
    Takahashi M
    Stem Cell Res; 2023 Sep; 71():103185. PubMed ID: 37639801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome editing-induced t(4;11) chromosomal translocations model B cell precursor acute lymphoblastic leukemias with KMT2A-AFF1 fusion.
    Pan F; Sarno J; Jeong J; Yang X; Jager A; Gruber TA; Davis KL; Cleary ML
    J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 37917159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia.
    Loftus JP; Yahiaoui A; Brown PA; Niswander LM; Bagashev A; Wang M; Schauf A; Tannheimer S; Tasian SK
    Haematologica; 2021 Apr; 106(4):1067-1078. PubMed ID: 32414848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Romidepsin enhances the efficacy of cytarabine
    Cheung LC; Cruickshank MN; Hughes AM; Singh S; Chua GA; Ford J; Ferrari E; Oommen J; Malinge S; Lock RB; Kees UR; Kotecha RS
    Haematologica; 2019 Jul; 104(7):e300-e303. PubMed ID: 30679330
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
    Urtishak KA; Wang LS; Culjkovic-Kraljacic B; Davenport JW; Porazzi P; Vincent TL; Teachey DT; Tasian SK; Moore JS; Seif AE; Jin S; Barrett JS; Robinson BW; Chen IL; Harvey RC; Carroll MP; Carroll AJ; Heerema NA; Devidas M; Dreyer ZE; Hilden JM; Hunger SP; Willman CL; Borden KLB; Felix CA
    Oncogene; 2019 Mar; 38(13):2241-2262. PubMed ID: 30478448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience.
    Richard-Carpentier G; Kantarjian HM; Tang G; Yin CC; Khoury JD; Issa GC; Haddad F; Jain N; Ravandi F; Short NJ; DiNardo CD; Takahashi K; Konopleva MY; Daver NG; Kadia T; Garcia-Manero G; Garris R; O'Brien S; Jabbour E
    Blood Adv; 2021 Dec; 5(23):5415-5419. PubMed ID: 34525185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A KMT2A-AFF1 gene regulatory network highlights the role of core transcription factors and reveals the regulatory logic of key downstream target genes.
    Harman JR; Thorne R; Jamilly M; Tapia M; Crump NT; Rice S; Beveridge R; Morrissey E; de Bruijn MFTR; Roberts I; Roy A; Fulga TA; Milne TA
    Genome Res; 2021 Jul; 31(7):1159-1173. PubMed ID: 34088716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia.
    Stevanović S; Griffioen M; Nijmeijer BA; van Schie ML; Stumpf AN; Rutten CE; Willemze R; Falkenburg JH
    Leukemia; 2012 Feb; 26(2):312-22. PubMed ID: 21860431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
    Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
    Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.
    Konantz M; André MC; Ebinger M; Grauer M; Wang H; Grzywna S; Rothfuss OC; Lehle S; Kustikova OS; Salih HR; Handgretinger R; Fend F; Baum C; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
    Leukemia; 2013 Jan; 27(1):56-65. PubMed ID: 22828445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of fusion circular RNAs in leukemia with KMT2A::AFF1 rearrangements by the new software CircFusion.
    Dal Molin A; Tretti Parenzan C; Gaffo E; Borin C; Boldrin E; Meyer LH; Te Kronnie G; Bresolin S; Bortoluzzi S
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36585787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An AF9/ENL-targted peptide with therapeutic potential in mixed lineage leukemias.
    Barretto NN; Karahalios DS; You D; Hemenway CS
    J Exp Ther Oncol; 2014; 10(4):293-300. PubMed ID: 25509985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.